(Logo: http://photos.prnewswire.com/prnh/20160210/331945LOGO )
The Award Committee recognized Laszlo Urge's scientific, technological and innovative achievements, particularly his contribution to the R&D 100 Award winning H-Cube technology and to Technology Enabled Medicinal Chemistry as well as his leading role in building successful organizations which develop and translate technologies into major commercial success. The Award highlighted his success firstly, in delivering the H-Cube technology into the top 20 pharmaceutical and biotechnology companies worldwide and secondly, driving significant collaboration among leading pharmaceutical and biotechnology companies on Technology Enabled Medicinal Chemistry, leading to the creation of a successful innovation ecosystem and job creation.
The Dennis Gabor Award is awarded by the NOVOFER Foundation to candidates who have shown outstanding scientific, technological and innovation achievement with practical applications and a clear positive attitude towards international co-operation between research and innovation. The Award is named in honour of the Nobel Prize winner Dennis Gabor and the awards committee selects the winner through a highly competitive process.
About DBH Group
The DBH Group is an international organisation that operates a comprehensive business infrastructure (serviced offices, serviced industrial facilities, IT), professional consultants (finance, taxation, IT, project management) in Europe (in the Netherlands, Austria, the Czech Republic, Croatia, Poland, Romania, Slovakia and Slovenia), venture capital investments for high tech companies as well as incubation and acceleration support for high tech start-ups. DBH's mission is to assist companies in regional and international expansion while helping them optimize their operations.
For more information about The DBH Group, see: http://www.dbh-group.com
SOURCE DBH Investment Zrt.